Page 158 - ADULT-ONSET ASTHMA PREDICTORS OF CLINICAL COURSE AND SEVERITY

ADULT-ONSET ASTHMA – PREDICTORS OF CLINICAL COURSE AND SEVERITY
Lung-Func on Tests European-Community for Steel and Coal - O cial Statement of the European Respiratory Society. European Respiratory Journal. 1993;6:53-83.
22. Dweik RA, Boggs PB, Erzurum SC, et al. An O cial ATS Clinical Prac ce Guideline: Interpreta on of Exhaled Nitric Oxide Levels (FENO) for Clinical Applica ons. American Journal of Respiratory and Cri cal Care Medicine. 2011;184(5):602-615.
23. Paggiaro PL, Chanez P, Holz O, et al. Sputum induc on. Eur.Respir.J Suppl. 2002;37:3s-8s.
24. Zeiger RS, Schatz M, Li Q, et al. High blood eosinophil count is a risk factor for future asthma exacer-
ba ons in adult persistent asthma. J Allergy Clin Immunol Pract. 2014;2(6):741-750.
25. Chipps BE, Zeiger RS, Borish L, et al. Key ndings and clinical implica ons from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. Journal of Allergy and Clinical Immunology. 2012;130(2):332-+.
26. Greenberg S, Liu N, Kaur A, et al. The asthma disease ac vity score: a discrimina ng, responsive measure predicts future asthma a acks. The Journal of allergy and clinical immunology. 2012;130(5):1071-1077 e1010.
27. Bateman ED, Buhl R, O’Byrne PM, et al. Development and valida on of a novel risk score for asthma exacerba ons: The risk score for exacerba ons. The Journal of allergy and clinical immunology. 2014.
28. Hurst JR, Vestbo J, Anzueto A, et al. Suscep bility to exacerba on in chronic obstruc ve pulmonary disease. N Engl J Med. 2010;363(12):1128-1138.
29. Bafadhel M, McKenna S, Terry S, et al. Acute exacerba ons of chronic obstruc ve pulmonary disease: iden ca on of biologic clusters and their biomarkers. Am J Respir Crit Care Med. 2011;184(6):662-671.
30. Thomson NC, Chaudhuri R, Heaney LG, et al. Clinical outcomes and in ammatory biomarkers in current smokers and exsmokers with severe asthma. Journal of Allergy and Clinical Immunology. 2013;131(4):1008-1016.
31. Lugade AA, Bogner PN, Thatcher TH, Sime PJ, Phipps RP, Thanavala Y. Cigare e smoke exposure exacerbates lung in amma on and compromises immunity to bacterial infec on. J Immunol. 2014;192(11):5226-5235.
32. Venarske DL, Busse WW, Gri n MR, et al. The rela onship of rhinovirus-associated asthma hospitali- za ons with inhaled cor costeroids and smoking. J Infect Dis. 2006;193(11):1536-1543.
33. Green BJ, Wiriyachaiporn S, Grainge C, et al. Poten ally pathogenic airway bacteria and neutrophilic in amma on in treatment resistant severe asthma. PLoS One. 2014;9(6):e100645.
34. Barnes PJ. Cor costeroid resistance in pa ents with asthma and chronic obstruc ve pulmonary disease. The Journal of allergy and clinical immunology. 2013;131(3):636-645.
35. Nair P, Aziz-Ur-Rehman A, Radford K. Therapeu c implica ons of ‘neutrophilic asthma’. Curr Opin Pulm Med. 2015;21(1):33-38.
36. Roche N, Postma DS, Colice G, et al. Di eren al e ects of inhaled cor costeroids in smokers/ex-smokers and nonsmokers with asthma. Am J Respir Crit Care Med. 2015;191(8):960-964.
37. Brusselle GG, Vanders chele C, Jordens P, et al. Azithromycin for preven on of exacerba ons in severe asthma (AZISAST): a mul centre randomised double-blind placebo-controlled trial. Thorax. 2013;68(4):322-329.
156